Where have all the T cells gone? Mechanisms of immune evasion by tumors
- 1 April 1999
- journal article
- Published by Elsevier in Immunology Today
- Vol. 20 (4) , 158-160
- https://doi.org/10.1016/s0167-5699(98)01435-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Repression of Interleukin-2 mRNA Translation in Primary Human Breast Carcinoma Tumor-Infiltrating LymphocytesCellular Immunology, 1998
- Impaired Activation of NFκB in T Cells From a Subset of Renal Cell Carcinoma Patients Is Mediated by Inhibition of Phosphorylation and Degradation of the Inhibitor, IκBBlood, 1998
- Fidelity of T Cell Activation Through Multistep T Cell Receptor ζ PhosphorylationScience, 1998
- Mechanisms Responsible for Signaling and Functional DefectsJournal of Immunotherapy, 1998
- Decreased Expression of Signal‐Transducing CD3 ζ Chains in T Cells from the Joints and Peripheral Blood of Rheumatoid Arthritis PatientsScandinavian Journal of Immunology, 1998
- Induction of antigen-specific T cell anergy: An early event in the course of tumor progressionProceedings of the National Academy of Sciences, 1998
- Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic AnergyThe Journal of Experimental Medicine, 1997
- Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigensLife Sciences, 1997
- T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.The Journal of Experimental Medicine, 1995
- Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitusDiabetes, 1984